Open access
Aug 2026
DEVELOPMENT AND VALIDATION OF A ROBUST RP-HPLC METHOD FOR QUANTIFICATION OF VONOPRAZAN FUMARATE IN PHARMACEUTICAL DOSAGE FORMS AND HUMAN PLASMA
Background: Vonoprazan Fumarate is a potassium-competitive acid blocker (P-CAB) that inhibits gastric H⁺, K⁺ ATPase, effectively reducing acid secretion and treating disorders such as Gastroesophageal Reflux Disease and Helicobacter pylori infection. Objective: This study aimed to develop and validate a simple, sensiti...
Suvarna V. Pawar, V. D. Kunde, K. B. Dhamak et al.
· Genetics and Molecular Resea... · 0 citations